Literature DB >> 27551338

Correlation of magnetic resonance signal characteristics and perfusion parameters assessed by volume perfusion computed tomography in hepatocellular carcinoma: Impact on lesion characterization.

Gerd Grözinger1, Michael Bitzer1, Roland Syha1, Dominik Ketelsen1, Konstantin Nikolaou1, Ulrich Lauer1, Marius Horger1.   

Abstract

AIM: To find out if magnetic resonance (MR)-signal characteristics of hepatocellular carcinomas (HCC) correlate with perfusion parameters assessed by volume perfusion computed tomography (VPCT).
METHODS: From October 2009 to January 2014, 26 (mean age, 69.3 years) patients with 36 HCC lesions who underwent both VPCT and MR liver imaging were analysed. We compared signal intensity in the T1w- and T2w-images and wash-in/wash-out kinetics on post-contrast MR images with mean values of blood flow (BF, mL/100 mL per minute), blood volume (BV, mL/100 mL), k-trans (mL/100 mL per minute), arterial liver perfusion (mL/100 mL per minute), portal venous perfusion and hepatic perfusion index (HPI, %) obtained by VPCT. Signal intensity on magnetic resonance imaging (MRI) was classified hyper/iso/hypointense compared with surrounding liver parenchyma.
RESULTS: Signal intensity on native T1w- and T2w-images was hyper/iso/hypo in 4/16/16 and 21/14/1 lesions, respectively. Wash-in and wash-out contrast kinetics were found on MRI in 33 of 36 lesions (91.7%) and 25 of 36 lesions (69.4%), respectively. The latter was observed significantly more often in higher graded lesions (P < 0.005). HPI was 94.7% ± 6.5%. There was no significant relationship between lesion's MR-signal intensity, MR signal combinations, size and any of the VPCT-perfusion parameters. However HPI was constantly high in all HCC lesions.
CONCLUSION: VPCT parameters add limited value to MR-lesion characterization. However in HCC lesions with atypical MR signal characteristics HPI can add a parameter to ensure HCC diagnosis.

Entities:  

Keywords:  Hepatocellular carcinoma; Magnetic resonance imaging; Volume perfusion computed tomography

Year:  2016        PMID: 27551338      PMCID: PMC4965352          DOI: 10.4329/wjr.v8.i7.683

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  20 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings.

Authors:  M Kadoya; O Matsui; T Takashima; A Nonomura
Journal:  Radiology       Date:  1992-06       Impact factor: 11.105

3.  Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm.

Authors:  Keiji Mita; Soo Ryang Kim; Masatoshi Kudo; Susumu Imoto; Taisuke Nakajima; Kenji Ando; Katsumi Fukuda; Toshiyuki Matsuoka; Yoko Maekawa; Yoshitake Hayashi
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

4.  MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns.

Authors:  Indra C van den Bos; Shahid M Hussain; Roy S Dwarkasing; Wim C J Hop; Pieter E Zondervan; Robert A de Man; Jan N M IJzermans; Craig W Walker; Gabriel P Krestin
Journal:  J Magn Reson Imaging       Date:  2007-12       Impact factor: 4.813

5.  Nodular regenerative hyperplasia, dysplasia, and hepatocellular carcinoma.

Authors:  I R Wanless
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

6.  Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.

Authors:  S Kaufmann; T Horger; A Oelker; C Kloth; K Nikolaou; M Schulze; M Horger
Journal:  Eur J Radiol       Date:  2015-03-06       Impact factor: 3.528

7.  Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis.

Authors:  Y N Park; Y B Kim; K M Yang; C Park
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

Review 8.  Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Lin-Na Liu
Journal:  World J Radiol       Date:  2014-01-28

Review 9.  Hepatocellular carcinoma variants: radiologic-pathologic correlation.

Authors:  Yong Eun Chung; Mi-Suk Park; Young Nyun Park; Hye-Jeong Lee; Jae Yeon Seok; Jeong-Sik Yu; Myeong-Jin Kim
Journal:  AJR Am J Roentgenol       Date:  2009-07       Impact factor: 3.959

Review 10.  Imaging of HCC-Current State of the Art.

Authors:  Christina Schraml; Sascha Kaufmann; Hansjoerg Rempp; Roland Syha; Dominik Ketelsen; Mike Notohamiprodjo; Konstantin Nikolaou
Journal:  Diagnostics (Basel)       Date:  2015-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.